Skip to main content
Premium Trial:

Request an Annual Quote

Gerald Möller

Gerald Möller has informed Illumina that he will retire from its board of directors, effective immediately before the firm's 2015 annual meeting of stockholders. He has been a director at Illumina since July 2010 and is currently an advisor at HBM Bio Ventures, a Swiss investment firm focusing on biotechnology, emerging pharma, and medical technology.